Evidence map›Paper›PMID 42808022›Full record

ArticleCurrent opinion in biomedical engineering2026

Gero-Immunology: The critical role of aging when defining immune phenotypes.

Ladaisha Thompson, Jude M Phillip

Abstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ladaisha ThompsonDepartment of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
Jude M PhillipDepartment of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, Maryland, USA.

Funding

Defining a biophysical basis for cell types, cell states and cellular heterogeneity at single-cell resolutionR35GM157099 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Jude Marvin Phillip · 2025 to 2026
$762k
NIGMS NIH HHS R35 GM157099
6 · The paper itself

Abstract

The immune system is complex, dynamic, and essential for organismal health. As organisms age, immune cells undergo numerous changes that often limit their ability to fight infections, eradicate diseases, and tolerate foreign entities. Although many studies have advanced our understanding of key immune functions, many overlook the effects of age, which can potentially limit the generalizability of their findings. In this review, we argue that age should be critically considered when designing in vitro models of the immune system. We begin by outlining some practical and conceptual challenges that limit the inclusion of age in immune models. We then propose practical strategies that researchers can use to account for age effects and summarize recent findings that demonstrate how aging alters cellular immune functions to drive immune dysfunction. Lastly, pose open questions that could benefit from bioengineering solutions and look ahead to how considering age can improve model fidelity, increase translational value, and accelerate discoveries that are both relevant and generalizable across the lifespan.

Identifiers

PMID42808022
PMCPMC13618701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.